Clinical Trial Update: The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the impact of rifampin on the metabolism of the Parkinson's disease drug istradefylline in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RIFAMPIN (RIFAMPIN)
• istradefylline (istradefylline)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED